<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358558/" ref="ordinalpos=1538&amp;ncbi_uid=4033518&amp;link_uid=PMC3358558" image-link="/pmc/articles/PMC3358558/figure/Fig6/" class="imagepopup">Fig. 6.  From: Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>. </a></div><br /><div class="p4l_captionBody">Protein expression of cell cycle and apoptosis regulatory proteins. Effects of CXB (20 Î¼M) on ERK1/2 signaling pathway phosphorylation (<b>a</b>), PCNA expression (<b>a</b>), Bax/Bcl-2 expression (<b>b</b>), caspase-3 cleavage (<b>b</b>), Cyclin A expression (<b>b</b>) and p21CIP/WAF1 expression (<b>b</b>). GAPDH was used as a loading control. *P &lt; 0.05 vs. control; n = 8. GAPDH served as a loading control</div></div>